Back

Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: drug safety and tolerability

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Pulmonary hypertension Pulmonary hypertension HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Stefano Zicchino

Teresa Masselli Mascia Hospital, San Severo (Italy)

6 More presentations in this session

Presentation thumbnail
Right ventricle systolic remodeling index is a new echocardiography parameter that predicts long time survival in patients with pulmonary hypertension
Professor O. Aguirre Zurita (Lima, PE)
Abstract Slides
Presentation thumbnail
Exercise-induced oxygen desaturation in patients with idiopathic pulmonary arterial hypertension
Professor S. Kucukoglu (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Accuracy and precision of systolic pulmonary pressure assessed by echocardiography among patients with pulmonary hypertension
Doctor A. Lescano (Gran Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Prevalence of adverse prognostic factors at diagnosis of pulmonary hypertension
Doctor A. Lavalle Cobo (Buenos Aires, AR)
Abstract
Presentation thumbnail
Right ventricle characterization in patients with severe pulmonary hypertension due to post tricuspid shunts in contrast with other etiologies.
Professor O. Aguirre Zurita (Lima, PE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Pulmonary hypertension

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources